Ceprate

Ceprate®

Oncology A product line that selectively removes cell lines–eg, stem cells from BM and peripheral blood before tumor-purging therapy, or removes T cells to ↓ GVHD in allograft recipients. See Marrow ablation.
References in periodicals archive ?
Under terms of the agreement, patients will not lose access to CellPro's CEPRATE stem cell selection system until an alternative is approved by the US Food and Drug Administration (FDA).
Last week, United States Federal District Judge Roderick McKelvie entered an injunction against CellPro's infringing Ceprate SC stem cell selection device.
Bothell, WA, announced the FDA has approved the company's label expansion for the Ceprate SC Stem Cell Concentration System.